Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 FY- Text added to 2021 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AACR, ABC, accredited, ADC, admission, affiliate, affiliated, Agarwal, Alexion, Algeria, algorithm, alleviate, AML, ancillary, Antengene, antibody, APA, Arab, argued, ARIPO, assay, attached, attributed, baby, Bangladesh, BCR, began, Bellberry, biomarker, bronchial, Brunei, Bruton, BTC, BTK, cast, Celcuity, chimeric, chloride, CI, confirmatory, consecutive, constant, convened, counterparty, CR, creation, ctDNA, curative, curve, customary, cyclophosphamide, de, deep, Deepa, deeper, deleted, deletion, delisted, delisting, DepMap, diffuse, dismissal, dismissed, dissolution, Distinguishing, DLBCL, DLBLC, Dominican, DOR, Drachman, duly, durable, Egypt, embedded, engine, enriched, enrichment, epithelial, exceeded, exceeding, exhaled, expiratory, explore, exploring, fashion, fault, feature, FeNO, FL, follicular, forge, FPI, fraction, fractional, freely, GCB, Georgia, germinal, goodwill, grace, Harvard, Hedging, holder, home, HREC, HutchMed, hyperactivate, hyperactivation, hyperglycemia, hypoglycemic, hyponatremia, hypophosphatemia, ibrutinib, ID, image, inactive, indolent, Inline, instructed, intermediate, intracellular, involuntary, Iran, irreversible, issuable, ivacaftor, Jonathan, Jordan, junior, Kalydeco, Karyopharm, KEAP, Keith, Kymera, Lastly, leaving, led, lethal, lethality, linear, Linkbase, loncastuximab, macroglobulinemia, macular, Map, Membership, Membrane, MFN, Millennium, MIT, mivavotinib, mo, Molineaux, monthly, Morocco, mortgage, NACFC, neighboring, NGS, NHL, Nigeria, nimble, nonsense, notably, notification, omitted, Orford, organelle, organizational, ORR, OS, page, pair, Pakianathan, Pakistan, paralog, path, PD, penetration, penny, permissible, phosphoinositide, phosphorylation, PK, polatuzumab, pooled, poorer, precisely, precision, prednisone, predominantly, pretreated, profound, proportionally, QD, radiographic, rapalog, rapamycin, rash, rational, reclassify, redacted, redeem, redefine, redemption, referenced, refine, refinement, regain, regular, remission, remodeling, remodelling, Republic, resale, rescind, resubstitution, rituximab, roughly, salvage, screen, Secretary, Selinexor, sequester, session, signature, spectrum, spleen, spouse, sqnsclc, STAMINA, stead, stem, Stephanie, substitute, substitution, Subtopic, Sunil, Susan, Sweat, SYK, Symposium, synthesizing, tafasitamab, tagged, Taxonomy, TEAE, text, thereunto, therewith, thing, thirty, thousand, timeframe, TORC, transplant, Trikafta, true, Tunisia, unblinded, unblinding, unclassified, underserved, undersigned, underwritten, undisclosed, unobservable, unselected, unsettled, upregulate, upstream, Uruguay, Uzbekistan, venetoclax, verify, verity, vi, vincristine, virtue, Waldenstrom, Ward, wholly, winding, WM, Wolff, Wong, worth, WT, XBRL, yearly
Removed:
accumulating, acted, Afinitor, allosteric, altered, anemia, anti, anticancer, antioxidant, applicability, arrest, Bayer, billing, binding, blinded, blocked, blood, BMS, Boehringer, brain, Cabometyx, cabozantinib, Cadillac, capecitabine, carcinoma, carfilzomib, Celgene, claiming, clarifying, clinic, compare, constipation, consume, consumption, CTEP, depleted, dexamethasone, die, differentiate, diverse, diversified, Dream, Eisai, Eli, emerged, endothelial, energy, ENTRATA, epidermal, ER, erlotinib, escape, essentially, excessively, expedient, explanation, exploratory, factor, favorably, fighting, formation, fuel, fundamentally, GlaxoSmithKline, glioma, glutamate, glutamine, glutathione, GmbH, growing, hallmark, headcount, hematological, immunosuppressive, Ingelheim, inhibited, interaction, internally, ipilimumab, KGaA, leader, leased, Lilly, liver, Lynparza, marked, master, maximal, MDS, Mekinist, Merck, metabolically, mild, Mine, modality, multikinase, myelosdysplastic, nausea, Nektar, Nexavar, noncancelable, nucleic, nucleotide, nutrient, olaparib, oncogene, oncometabolism, OPDIVO, overexpressed, partner, pazopanib, PCT, Pharma, photophobia, practical, progressed, progression, pronounced, Qualitative, Quantitative, ras, reevaluate, reimburse, relieving, renal, rental, repair, Rewired, Roche, selectivity, selumetinib, sensitive, Somatic, sorafenib, Squibb, stand, starve, starved, stimulate, stratified, strongly, sunitinib, Supplementary, Sutent, synergistic, synergistically, systemic, Tarceva, TNBC, topline, Toricel, toxicity, toxicological, trametinib, transcriptional, triple, unaffected, Unresolved, uptake, vascular, vivo, vomiting, Votrient, Western
Valuein 2020 FY filing- Value in 2021 FY filing
Original filings
Filing view